uniQure N.V. - Ordinary Shares (QURE): Price and Financial Metrics

QURE POWR Grades

• QURE scores best on the Sentiment dimension, with a Sentiment rank ahead of 71.23% of US stocks.
• QURE's strongest trending metric is Value; it's been moving down over the last 177 days.
• QURE ranks lowest in Stability; there it ranks in the 5th percentile.

QURE Stock Summary

• Of note is the ratio of UNIQURE NV's sales and general administrative expense to its total operating expenses; merely 9.27% of US stocks have a lower such ratio.
• With a price/sales ratio of 19.55, UNIQURE NV has a higher such ratio than 94.16% of stocks in our set.
• As for revenue growth, note that QURE's revenue has grown -87.72% over the past 12 months; that beats the revenue growth of merely 1.44% of US companies in our set.
• Stocks that are quantitatively similar to QURE, based on their financial statements, market capitalization, and price volatility, are ENTA, RAPT, SELB, RNA, and XENE.
• QURE's SEC filings can be seen here. And to visit UNIQURE NV's official web site, go to www.uniqure.com.

QURE Valuation Summary

• QURE's price/earnings ratio is -9.7; this is 141.45% lower than that of the median Healthcare stock.
• QURE's EV/EBIT ratio has moved down 7.2 over the prior 70 months.

Below are key valuation metrics over time for QURE.

QURE Growth Metrics

The 2 year cash and equivalents growth rate now stands at 53.46%.
• Its 4 year net income to common stockholders growth rate is now at -69.58%.
• Its 2 year net cashflow from operations growth rate is now at 388.52%.

Over the past 15 months, QURE's revenue has gone down $438,768,000.

The table below shows QURE's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	61.429	-137.47	-125.388
2022-06-30	61.969	-128.636	-114.062
2022-03-31	525.34	303.521	324.467
2021-12-31	524.002	287.959	329.589
2021-09-30	500.397	297.874	320.682
2021-06-30	500.197	303.322	303.438

QURE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• QURE has a Quality Grade of C, ranking ahead of 27.42% of graded US stocks.
• QURE's asset turnover comes in at 0.884 -- ranking 28th of 682 Pharmaceutical Products stocks.
• OVID, ACER, and SCYX are the stocks whose asset turnover ratios are most correlated with QURE.

The table below shows QURE's key quality metrics over time.